Universitätsspital Zürich (USZ)

Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression (2026) Wahnschaffe L, Jungherz D, Müller TA, Pemovska T, Pichler A, Poulain S, Julia E, et al. Journal article Myeloid-derived immunosuppression of chimeric antigen receptor T cells in the neuronal microenvironment of glioblastoma (2026) Zhang J, von Ehr J, Look T, Benotmane JK, Neidert N, Kueckelhaus J, Weiss T, et al. Journal article Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma (2026) Dummer R, Sandhu S, Miller WH, Butler MO, Taylor MH, Heinzerling L, Blank CU, et al. Journal article TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas (2026) Hoogstrate Y, Ghisai SA, van Hijfte L, Head R, de Heer I, Padovan M, de Wit M, et al. Journal article Clinical evidence and reporting standards in reirradiation: Insights from 28 studies at ESTRO 2025, endorsed by the ESTRO reirradiation focus group (2026) Beddok A, Appelt AL, Corradini S, Duffton A, Petrianni GM, Tomasik B, Vásquez Osorio E, et al. Journal article Advancing CNS tumor diagnostics with expanded DNA methylation-based classification (2026) Sill M, Schrimpf D, Patel A, Sturm D, Jäger N, Sievers P, Schweizer L, et al. Journal article Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries (2026) Von Hoff K, Obrecht-Sturm D, Ghasemi DR, Wenning J, Mynarek M, Gerber NU, Benesch M, et al. Journal article Ethical considerations in randomization for neurosurgical oncology trials: A scoping review (2026) Shlobin NA, Hasner MC, Karschnia P, Widhalm G, Petrescu GE, Schucht P, Picart T, et al. Journal article, Review article Multicenter analysis of MRI-guided, stereotactic body radiotherapy as ablative treatment for lymph nodal metastases of the abdomen and pelvis. (2026) von der Grün J, Regnery S, Hörner-Rieber J, Hoegen-Saßmannshausen P, Andratschke N, Tanadini-Lang S, Guckenberger M, et al. Journal article DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers (2026) Schnellhardt S, Böke S, Tribius S, Krause M, Haderlein M, Rühle A, Süß C, et al. Journal article